Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2016

01-12-2016 | Editorial

What Will It Take to Reduce the App Gap?

Authors: Lyn Paget, MPH, Dominick L. Frosch, PhD

Published in: Journal of General Internal Medicine | Issue 12/2016

Login to get access

Excerpt

Right now you may be reading this editorial on your phone or tablet. Today we often work, play, plan travel, chat, read, bank, dine, or shop with the help of a mobile application (app). Consumers can browse from over 4 million Apple and Android mobile apps in an ever-increasing number of lifestyle categories.1 For adult users, the estimated average time spent on mobile digital media has increased from approximately 20 min per day in 2008 to close to 3 h per day in 2015.2 For those around to remember, our relationship with mobile technology began in 1973 with the first mobile phone. Weighing in at about 2.5 pounds and costing close to $4,000, the early adopters incurred hefty monthly fees and costs for minutes used. Thirty-four years later, Apple introduced the increasingly ubiquitous iPhone. These and other key milestones in the mobile digital media story have shaped an accelerating trajectory of ready access to information, instantaneous communication and unprecedented global connection. …
Literature
10.
go back to reference Powell AC, Landman AB, Bates DW. In search of a few good apps. JAMA. 2014;18:1851–1852.CrossRef Powell AC, Landman AB, Bates DW. In search of a few good apps. JAMA. 2014;18:1851–1852.CrossRef
Metadata
Title
What Will It Take to Reduce the App Gap?
Authors
Lyn Paget, MPH
Dominick L. Frosch, PhD
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3831-y

Other articles of this Issue 12/2016

Journal of General Internal Medicine 12/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.